1274. Activity of Ceftolozane/Tazobactam, Imipenem/Relebactam, and Comparators Against Pseudomonas aeruginosa Isolates from Patients with Bloodstream and Other Infection Types—SMART United States/Canada 2018-2019

BACKGROUND: Ceftolozane/tazobactam (C/T), an antipseudomonal cephalosporin combined with a β-lactamase inhibitor, was approved for treatment of complicated urinary tract (cUTI) and intraabdominal infections (cIAI), and hospital-acquired/ventilator-associated bacterial pneumonia (HAP/VAP). Imipenem/r...

Descripción completa

Detalles Bibliográficos
Autores principales: Lob, Sibylle, Hackel, Meredith, Andrew DeRyke, C, Harris, Kelly, Young, Katherine, Motyl, Mary, Sahm, Daniel F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644582/
http://dx.doi.org/10.1093/ofid/ofab466.1466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644582/
http://dx.doi.org/10.1093/ofid/ofab466.1466

Ejemplares similares